Corcept Therapeutics
CORT
#2837
Rank
NZ$10.10 B
Marketcap
NZ$94.10
Share price
-2.22%
Change (1 day)
-25.41%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$0.75

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.77. In 2025 the company made an earnings per share (EPS) of NZ$1.60 a decrease over its 2024 EPS that were of NZ$2.30.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.75-53.55%
2025NZ$1.60-30.37%
2024NZ$2.30
2022NZ$1.62-2.06%
2021NZ$1.665.43%
2020NZ$1.5710.84%
2019NZ$1.4227.69%
2018NZ$1.11-42.48%
2017NZ$1.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.91 1,841.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.98 1,460.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.24 191.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.19 6,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.07 690.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.08 691.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.17-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.85-211.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.39 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA